AI matches expert radiologists in spotting prostate cancer

NCT ID NCT06575361

Completed Diagnosis Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether an artificial intelligence (AI) system could help find prostate cancer on MRI scans. 365 men who needed a prostate biopsy had their MRI images reviewed by both the AI and by senior radiologists. Doctors then performed targeted biopsies on any suspicious areas found by either the AI or the radiologists. The goal was to see if the AI could detect clinically significant prostate cancer as accurately as the experts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MRI artificial intelligence (MRI-AI) software
What this could lead to: If successful, MRI-AI could help doctors find prostate cancer more accurately and reduce unnecessary biopsies.
What could go wrong: This is a completed study, but AI may not work as well in all hospitals or on different MRI machines. It also cannot replace a doctor's final judgment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Peking University First Hospital

Beijing, Beijing Municipality, 100034, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.